维普中文期刊产品整合服务
12篇 您的检索式:作者名="Perry BN"
    题名 作者 年代 出处 被引量
1Virtual reality therapies for phantom limb pain 显示文摘Perry BN Mercier C Pettifer SR 2014Eur J Pain2014,18,7:1
2Evidence for the validity of'the Short - form 36 Questionnaire (SF - 36 ) in an elderly population 显示文摘Lyons RA Perry HM Little page BN 1994Age and Ageing1994,23,3:1
3Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice显示文摘Perry BN Govindarajan B Bhandarkar SS 2006J Invest Dermatol2006,126,:1
4The duality of angiogenesis : implications for therapy of human disease 显示文摘Perry BN Arbiser JL 2006J Invest Dermatol2006,126,10:1
5Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice显示文摘Perry BN Govindarajan B Bhandarkar SS 2006J Invest Dermatol2006,126,:1
6Pharmacologic blockade of Angiopoietin-2 is efficacious against model hemangiomas in mice显示文摘Perry BN Govindarajan B Bhandarkar SS 2006J Invest Dermatol2006,126,:1
7Evidence for the validity of the short-form 36 questionnaire (SF-36) in an elderly population显示文摘Lyons RA Perry HM Littlepage BN 1994Age Aging1994,23,3:1
8Pharlogic blockade of angiopoietin-2 is efficacious a- t model hemangiomas in mice显示文摘Perry maco gains derm BN Govindarajan B Bhandarkar SS 2006Investigative atology2006,126,10:1
9Evidence for the validity of the Short -form 36 Questionnaire (SF- 36) in an elderly popula- tion显示文摘Lyons RA Perry IM Littlepage BN 1994Age Ageing1994,23,3:1
10The duality of angiogenesis:implications for therapy of human disease显示文摘Perry BN Arbiser JL 2006J Invest Dermatol2006,126,10:1
11Evidence for the validity of the Short-form 36 Questionnaire (SF-36) in an elderly population显示文摘Lyons RA Perry HM Littlepage BN 1994Age Ageing1994,23,3:1
12Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice显示文摘Perry BN Govindarajan B Bhandarkar SS 2006J Invest Dermatol2006,126,10:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费